Physician profile
Marcus Ryan Gillon
NPI 1033603030
$2,169.15
in general payments reported to CMS, 2019-2025
6 companies · $649 in 2025
The $649 reported for 2025 was more than what 77% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $22.55 · 2021: $213 · 2022: $147 · 2023: $227 · 2024: $806 · 2025: $649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,682.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,530.16 | 2020-2025 | Matrixmandible, Trumatch, Matrixmidface |
| Axogen | $398.44 | 2019-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Zimmer Biomet Holdings, INC. | $92.71 | 2021 | |
| Stryker Corporation | $60.32 | 2024 | Na |
| Medical Device Business Services, INC. | $49.86 | 2019 | |
| Integra Lifesciences Corporation | $37.66 | 2024 | Cusa Clarity, Codman Hakim, Codman Certas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Gillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.